Ann Neurol
- PISA M, Lockhart A, Angell T, Avery A, et al
Topographical Variation of Iron-Rimmed Lesions in the Multiple Sclerosis Brain
and Spinal Cord: A Neuropathological Study.
Ann Neurol. 2026 Jan 18. doi: 10.1002/ana.78113.
BMC Neurol
- CAO J, Wang S, Gong T, Zheng W, et al
MR neurography of tibial and common peroneal nerves in patients with
Guillain-Barre syndrome and electrophysiological correlation.
BMC Neurol. 2026 Jan 23. doi: 10.1186/s12883-025-04618.
- LEEUWENBERG KE, van der Molen LH, Boenink M, Richard E, et al
The evolution of disease criteria in multiple sclerosis: underlying motives and
broader implications.
BMC Neurol. 2026 Jan 23. doi: 10.1186/s12883-026-04641.
- KUCUKKAYA B, Kaydirak M
The effect of multiple sclerosis on functional status and sexual quality of life
in female patients with multiple sclerosis.
BMC Neurol. 2026 Jan 22. doi: 10.1186/s12883-025-04584.
- ABUHAMMAD A, Ayyad M, Albandak M, AbuKhalaf SM, et al
Double-seronegative myasthenia gravis: clinical characteristics, treatment, and
outcomes - a systematic review of case reports and case series.
BMC Neurol. 2026 Jan 20. doi: 10.1186/s12883-026-04644.
- YIN N, Li C, Zhao J, Cao Y, et al
Development of a self-management journey map for people with multiple sclerosis:
a qualitative study.
BMC Neurol. 2026 Jan 19. doi: 10.1186/s12883-026-04631.
Curr Opin Immunol
- MEGHASHYAM S, Serajee FJ, Prakash AV, Altinok D, et al
Primary angiitis of the central nervous system.
Curr Opin Immunol. 2026;98:102691.
- ELSAGHIR A, Witte T
New autoantibodies in Sjogren's disease.
Curr Opin Immunol. 2026;99:102722.
Diabetes
- JIA X, Zhang C, Waugh K, Miao D, et al
Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With
a Novel Bridging ELISA.
Diabetes. 2026 Jan 12:db250696. doi: 10.2337/db25-0696.
- PITA-GRISANTI V, Martins Pecanha FL, Louzada RA, Blandino-Rosano M, et al
Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.
Diabetes. 2025 Nov 14:db250348. doi: 10.2337/db25-0348.
- GALDERISI A, Carr ALJ, Taylor P, Bonet J, et al
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1
Diabetes.
Diabetes. 2025 Nov 14:db250801. doi: 10.2337/db25-0801.
- RUCHI FNU, Schiavon M, Pandey A, Dalla Man C, et al
Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes.
Diabetes. 2025 Nov 20:db250587. doi: 10.2337/db25-0587.
- WILSON CS, Stocks BT, Falk AC, Moore DJ, et al
B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.
Diabetes. 2025 Nov 25:db250241. doi: 10.2337/db25-0241.
- ZHAO LP, Papadopoulos GK, Skyler JS, Parikh HM, et al
Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease
Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes.
Diabetes. 2025 Dec 3:db250610. doi: 10.2337/db25-0610.
- TRIOLO TM, Sosenko JM, Cuthbertson D, Oram RA, et al
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.
Diabetes. 2025 Dec 10:db250711. doi: 10.2337/db25-0711.
Intern Med
- MIYAMOTO AT, Kumanogoh A, Nishide M
Current Overview of Multi-omics Analyses in Microscopic Polyangiitis and
Granulomatosis with Polyangiitis.
Intern Med. 2026;65:226-232.
- BERCIANO J
Hyperacute Guillain-Barre Syndrome: A Pathophysiological Interpretation.
Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6808.
- ODA N, Kobayashi S, Nakano K
GAVE in Systemic Sclerosis with Concurrent Autoimmune Gastritis.
Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6785.
- HIRANO K, Kondo K, Saito T, Takahashi K, et al
Steroid-Resistant Relapse of Autoimmune Pancreatitis with Marked Main Pancreatic
Duct Dilatation Mimicking Multifocal Pancreatic Cancer.
Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6704.
- YASUI S, Nishimura K, Tanimoto Y, Mugitani M, et al
A Case of Diffuse Large B-cell Lymphoma Presenting with Protein-losing
Enteropathy During Treatment for Systemic Lupus Erythematosus.
Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.5934.
J Autoimmun
- LEIJDING C, Gastaldello S, Schiffer T, Kaewin S, et al
Sera from patients with dermatomyositis and antisynthetase syndrome mediate
muscle weakness, impair mitochondrial respiration and induce local cytokine
production in muscle tissue.
J Autoimmun. 2026;158:103522.
- DESALEGN D, Fischer S, Bedada Y, Freuer D, et al
Autoimmunity to mental health: Risk of depression in type 1 diabetes and celiac
disease patients - A systematic review, meta-analysis, and bias assessment.
J Autoimmun. 2026;158:103524.
- BERETTA L, Chan CWS, Moysidou GS, Nothling DM, et al
Molecular stratification and transcriptome-guided therapeutics in systemic lupus
erythematosus with insufficient treatment response.
J Autoimmun. 2026;159:103525.
J Clin Endocrinol Metab
- LAHOTI A, Haque MR, Bianco ME, Chaudhary A, et al
Trends of Diabetes in Youth (TrenDY) during COVID-19 across the United States.
J Clin Endocrinol Metab. 2025 Jul 14:dgaf395. doi: 10.1210.
- PRAHALAD P, Ding VY, Zaharieva DP, Addala A, et al
Sustained HbA1c Improvements Over 36 Months in Youth in the Teamwork, Targets,
Technology, and Tight Control (4T) Study.
J Clin Endocrinol Metab. 2026;111:418-426.
- STECK AK, Parikh HM, Triolo TM, Ferrat L, et al
Genetic Risk and Transition through Preclinical Stages of Type 1 Diabetes.
J Clin Endocrinol Metab. 2025 Jul 9:dgaf392. doi: 10.1210.
-
Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug
Discontinuation on Relapse Risk in Graves' Disease".
J Clin Endocrinol Metab. 2026 Jan 22:dgag016. doi: 10.1210.
- STAN MN, Toro-Tobon D
Graves' Disease: A New Era of Pathophysiology-Guided Therapeutics.
J Clin Endocrinol Metab. 2026 Jan 13:dgag010. doi: 10.1210.
- LEE JE, Chillon TS, Minich WB, Abel BS, et al
Insulin Receptor Family Autoantibodies in Patients with Type B insulin
Resistance.
J Clin Endocrinol Metab. 2026 Jan 12:dgaf692. doi: 10.1210.
J Neuroimmunol
- SIMONE K, Nathoo N, Hooper A, Aboseif A, et al
Immature ovarian teratomas in anti-NMDA receptor encephalitis.
J Neuroimmunol. 2026;412:578850.
- MURAKAMI K, Tsujimoto H, Nakayama Y, Takeuchi H, et al
The activation of classical and/or lectin complement pathway for the pathogenesis
of chronic inflammatory demyelinating polyradiculoneuropathy.
J Neuroimmunol. 2026;412:578848.
- KIMURA A, Takekoshi A, Miyazaki Y, Oh-Hashi K, et al
TMEM132A autoimmunity in patients with suspected autoimmune cerebellar ataxia.
J Neuroimmunol. 2026;413:578867.
J Rheumatol
- PLANTINGA LC, Fitzpatrick J, Dey M, Dall'Era M, et al
Perceived and Objective Physical Function in Two U.S., Population-Based Cohorts
of Adults with Systemic Lupus Erythematosus.
J Rheumatol. 2026 Jan 15:jrheum.2025-0857. doi: 10.3899/jrheum.2025-0857.
Kidney Int
- CANNEY M, Shan S, Er L, Billot L, et al
A secondary analysis of the TESTING trial predicted individual patient response
to corticosteroid treatment in IgA nephropathy.
Kidney Int. 2026 Jan 20:S0085-2538(26)00005-0. doi: 10.1016/j.kint.2025.
- LIU X, Wang L, Lin M, Jia N, et al
Multi-omics analyses reveal the pathogenic role of terminal ileum-derived
IgA(+)beta7(+) cells in IgA nephropathy.
Kidney Int. 2026 Jan 20:S0085-2538(26)00010-4. doi: 10.1016/j.kint.2025.
Lancet
- ABIZAID A, Mehran R, Oliva A, Chamie D, et al
Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in
patients with diabetes and coronary artery disease (ABILITY Diabetes Global):
results from a multicentre, randomised controlled trial.
Lancet. 2026 Jan 8:S0140-6736(25)02157-9. doi: 10.1016/S0140-6736(25)02157.
Mult Scler
- PRETZSCH R, El Mahdaoui S, Johnson P, Soares MD, et al
Neurofilament light chain as a surrogate candidate for disease activity in
multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials.
Mult Scler. 2026 Jan 23:13524585251407973. doi: 10.1177/13524585251407973.
- KUMARI S, Stephens S, Yoo PY, Arbour-Nicitopoulos KP, et al
Built-environment correlates of physical activity in youth with multiple
sclerosis.
Mult Scler. 2026 Jan 20:13524585251407505. doi: 10.1177/13524585251407505.
- VAN DER WALT A
Multiple sclerosis controversies: Detecting progressing events in MS clinics in
real-time is possible-commentary.
Mult Scler. 2026 Jan 14:13524585251409579. doi: 10.1177/13524585251409579.
- NESBITT C, Van Der Walt A, Butzkueven H, Rath L, et al
Violence and multiple sclerosis: Towards an evidence-informed call to action in
neurology.
Mult Scler. 2026 Jan 13:13524585251409580. doi: 10.1177/13524585251409580.
Neurology
- TEO KSH, Kwan MYK, Qu D, Lim LHP, et al
Patient Perspective: Words That Matter: Reflections on a Patient's Experiences
With Guillain-Barre Syndrome.
Neurology. 2026;106:e214685.
- LOCKHART A, Pisa M, Drakesmith H, DeLuca GC, et al
Iron-Rim Lesions in the Optic Chiasm in Multiple Sclerosis: A Neuropathologic
Case Series.
Neurology. 2026;106:e214515.
- CAGOL A, Granziera C
Turning Our Gaze to the Anterior Visual Pathway: Iron Rim Lesions Come Into View
in Multiple Sclerosis.
Neurology. 2026;106:e214590.
PLoS One
- YANG D, Zhang Y, Ji L, Wu J, et al
The shared biomarkers and molecular mechanisms of systemic lupus erythematosus
and type 2 diabetes.
PLoS One. 2026;21:e0340312.
Proc Natl Acad Sci U S A
- GERVAIS A, Bastard P, Zhang Q, Jaffar-Bandjee MC, et al
Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine
encephalitis.
Proc Natl Acad Sci U S A. 2026;123:e2532212123.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016